These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 8030221)

  • 1. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection.
    Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA
    Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional modules important for activated expression of early genes of herpes simplex virus type 1 are clustered upstream of the TATA box.
    Pande NT; Petroski MD; Wagner EK
    Virology; 1998 Jun; 246(1):145-57. PubMed ID: 9657002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter.
    Kenny JJ; Krebs FC; Hartle HT; Gartner AE; Chatton B; Leiden JM; Hoeffler JP; Weber PC; Wigdahl B
    Virology; 1994 Apr; 200(1):220-35. PubMed ID: 8128624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
    Grant KG; Krisky DM; Ataai MM; Glorioso JC
    Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT; Wagner EK
    Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
    Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
    J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
    Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
    Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor.
    Hilton MJ; Mounghane D; McLean T; Contractor NV; O'Neil J; Carpenter K; Bachenheimer SL
    Virology; 1995 Nov; 213(2):624-38. PubMed ID: 7491786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of regulatory functions of the HSV-1 immediate-early protein ICP22.
    Prod'hon C; Machuca I; Berthomme H; Epstein A; Jacquemont B
    Virology; 1996 Dec; 226(2):393-402. PubMed ID: 8955059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the initiator and downstream promoter elements of herpes simplex virus 1 late genes.
    Woerner AM; Weir JP
    Virology; 1998 Sep; 249(2):219-30. PubMed ID: 9791014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts.
    Lee LY; Schaffer PA
    J Virol; 1998 May; 72(5):4250-64. PubMed ID: 9557715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription.
    Chen YM; Knipe DM
    Virology; 1996 Jul; 221(2):281-90. PubMed ID: 8661438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upstream stimulatory factor family binds to the herpes simplex virus type 1 latency-associated transcript promoter.
    Kenny JJ; Millhouse S; Wotring M; Wigdahl B
    Virology; 1997 Apr; 230(2):381-91. PubMed ID: 9143295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The equine herpesvirus type 1 immediate-early gene product contains an acidic transcriptional activation domain.
    Smith RH; Zhao Y; O'Callaghan DJ
    Virology; 1994 Aug; 202(2):760-70. PubMed ID: 8030239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16.
    Griffith C; Noonan S; Lou E; Shillitoe EJ
    Cancer Gene Ther; 2007 Dec; 14(12):985-93. PubMed ID: 17853922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of anisomorphic DNA conformations in the negative regulation of a herpes simplex virus type 1 promoter.
    Sarisky RT; Weber PC
    Virology; 1994 Nov; 204(2):569-79. PubMed ID: 7941324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter.
    Gu B; Rivera-Gonzalez R; Smith CA; DeLuca NA
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9528-32. PubMed ID: 8415735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High efficiency transient expression of eukaryotic genes: use of an HSV-1 immediate early promoter (ICP4).
    Liu X; Giza CC; Vrana KE
    Biotechniques; 1990 Aug; 9(2):168-73. PubMed ID: 2169263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-Competent Controlled Herpes Simplex Virus.
    Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
    J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4.
    Samaniego LA; Webb AL; DeLuca NA
    J Virol; 1995 Sep; 69(9):5705-15. PubMed ID: 7637016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.